Phase II feasibility study of paclitaxel (T) with trastuzumab (H) and lapatinib (L) for node-negative, HER2-positive breast cancer (BC) Meeting Abstract
| Authors: | Iyengar, N. M.; Fornier, M. N.; Sugarman, S.; Theodoulou, M.; Troso-Sandoval, T. A.; D'Andrea, G.; Drullinsky, P.; Fasano, J.; Gajria, D.; Goldfarb, S. B.; Comen, E. A.; Lake, D.; Modi, S.; Traina, T. A.; Chen, M.; Patil, S.; Baselga, J.; Norton, L.; Hudis, C. A.; Dang, C. T. |
| Abstract Title: | Phase II feasibility study of paclitaxel (T) with trastuzumab (H) and lapatinib (L) for node-negative, HER2-positive breast cancer (BC) |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613202406 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.633 |
| Notes: | Meeting Abstract: 633 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
